Biobank Carcinoma: Storing Blood and Protein of Patients With Cancer

This study is currently recruiting participants.

Verified December 2012 by Maastricht Radiation Oncology

Sponsor:

Collaborator:

Maastricht University Medical Center

Information provided by (Responsible Party):

Maastricht Radiation Oncology

ClinicalTrials.gov Identifier:

NCT01084785

First received: March 10, 2010

Last updated: December 27, 2012

Last verified: December 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	January 2025
Estimated Primary Completion Date:	January 2025 (Final data collection date for primary outcome measure)

No publications provided by Maastricht Radiation Oncology

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Dehing-Oberije C, Aerts H, Yu S, De Ruysscher D, Menheere P, Hilvo M, van der Weide H, Rao B, Lambin P. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325). Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):360-8. Epub 2010 Oct 1.

To Top